How much is the thin film drug manufacturing market worth, and how is it expected to expand?
The thin film drug manufacturing market size has grown strongly in recent years. It will grow from $7.98 $ billion in 2024 to $8.71 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing patient demand for convenient drug delivery, the growing prevalence of chronic diseases, regulatory approvals for innovative dosage forms, rising healthcare costs and demand for cost-effective solutions, and enhancing the bioavailability and efficacy of thin film formulations.
The thin film drug manufacturing market size is expected to see strong growth in the next few years. It will grow to $12.27 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the increasing prevalence of chronic conditions, advancements in formulation science and materials engineering, rising demand for personalized and targeted drug delivery, supportive regulatory pathways and favorable reimbursement policies, and increasing adoption of e-commerce for drug distribution. Major trends in the forecast period include advancements in smart and responsive drug delivery systems, increased focus on combining multiple drugs in a single film, the evolution of more sustainable and eco-friendly manufacturing processes, the integration of digital technologies with thin film drug delivery, and the development of innovative solutions for taste masking and improved patient experience.
Get Your Free Sample of The Global Thin Film Drug Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19730&type=smp
Which industry factors have accelerated the thin film drug manufacturing market’s expansion?
The increase in the global elderly population is expected to propel the growth of the thin-film drug manufacturing market going forward. The rise in the global elderly population is influenced by extended life expectancies, medical advancements, improved nutrition and healthcare, and changes in family structures and societal norms. Thin film drug manufacturing helps meet the needs of the growing elderly population by offering improved medication adherence, ease of use, precise dosage control, rapid dissolution, and enhanced stability, which together supports better management of chronic conditions and overall health in older adults. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Therefore, the increase in the global elderly population is driving the thin film drug manufacturing market.
What are the primary segments of the thin film drug manufacturing market?
The thin film drug manufacturingmarket covered in this report is segmented –
1) By Type: Oral Thin Film, Transdermal Film, Other Types
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce
Subsegments:
1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films
2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films
3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/thin-film-drug-manufacturing-global-market-report
Which firms are leading the thin film drug manufacturing market?
Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy’s Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.
Which market trends are set to define the future of the thin film drug manufacturing market?
Major companies operating in the thin film drug manufacturing market are focusing on developing innovative products, such as oral thin film technologies, to enhance patient compliance and ease of use. Oral thin film technologies involve creating rapidly dissolving films that deliver medication through the mucous membranes in the mouth for quick absorption. These films offer a convenient, effective, and user-friendly alternative to traditional oral dosage forms such as tablets and capsules. For instance, in April 2023, IntelGenx Corporation, a Canada-based pharmaceutical company, announced the Food and Drug Administration (FDA) approval of RIZAFILM for the treatment of acute migraine. This new formulation allows for rapid dissolution and absorption, potentially providing faster relief for migraines compared to traditional tablets. This innovation enhances bioavailability and offers a more convenient, user-friendly option, improving patient compliance. The thin film technology enhances patient compliance and ease of use, making it a more user-friendly alternative for managing acute migraine attacks.
Which geographic trends are shaping the thin film drug manufacturing market, and which region has the highest market share?
North America was the largest region in the thin film drug manufacturing market in 2024. The regions covered in the thin film drug manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Thin Film Drug Manufacturing Market Report 2025 Offer?
The thin film drug manufacturing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Thin film drug manufacturing involves creating pharmaceutical products in the form of thin, flexible films that dissolve quickly when placed in the mouth. This method enhances drug absorption and patient compliance by providing a convenient and effective delivery system. It is often used for medications requiring a rapid onset of action or those that are difficult to swallow.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19730
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
